Revance Therapeutics RVNC 深 沪
等待开盘 04-02 09:30:00 美东时间
3.65
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 3.65
- 总市值 3.80亿
- 52周最高 7.56
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.30
- 委 比 0.00%
- 总股本 1.04亿
- 历史最高 42.41
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.30
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RVNC Lawsuit Alert! Class Action Against Revance Therapeutics, Inc.
Aclass actionlawsuit was filed against Revance Therapeutics, Inc. (...
2025-02-21 19:59
BRIEF-Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Feb 5 (Reuters) - Revance Therapeutics Inc RVNC.O: CROWN LABORATORIES AND REVANCE THERAPEUTICS ANNOUNCE EXPIRATION OF TENDER OFFER Source text: ID:nPn4FYcHma Further company coverage: RVNC.O ((Reuters...
2025-02-05 21:05
Teoxane withdraws takeover offer for Revance Therapeutics
Teoxane withdrew its $3.60 a share offer for Revance Therapeutics after Crown Labs raised its offer to $3.65. Revance ticked lower by 0.3% in premarket trading. Teoxane said that committed financing i...
2025-01-30 22:16
U.S. RESEARCH ROUNDUP- Capital One Financial, Netflix, Regeneron Pharmaceuticals
Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Capital One Financial, Netflix and Regeneron Pharmaceuticals, on ...
2025-01-22 14:40
BRIEF-Crown Laboratories And Revance Amend A&R Merger Agreement
Jan 21 (Reuters) - Revance Therapeutics Inc RVNC.O: CROWN LABORATORIES AND REVANCE AMEND THE A&R MERGER AGREEMENT TO INCREASE OFFER PRICE TO $3.65 PER SHARE AND EXTEND EXISTING TENDER OFFER INCREASED ...
2025-01-21 21:43
BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, natgas firms, Citigroup
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on...
2025-01-07 00:05
UPDATE 1-Teoxane makes higher offer for Botox rival maker Revance
Adds deal details in paragraphs 2,10 and background in paragraphs 6 to 9 Jan 6 (Reuters) - Teoxane SA on Monday disclosed a higher bid for Revance Therapeutics RVNC.O, nearly a month after the anti-wr...
2025-01-06 23:23
BUZZ-Revance Therapeutics gains after Teoxane's buyout proposal
** Shares of anti-wrinkle injection maker Revance Therapeutics RVNC.O gain 15.7% to $3.57 ** Privately held Swiss medical aesthetics company Teoxane proposed to acquire RVNC for $3.60 per share in cas...
2025-01-06 22:58
Revance Therapeutics jumps after Teoxane offers $3.60 a share
Revance Therapeutics (NASDAQ:RVNC) soared 16% after Teoxane offered to purchase the company for $3.60 a share in cash, above Crown Therapeutics $3.10 a share deal. Teoxane, which beneficially owns 6....
2025-01-06 22:50
Teoxane offers superior proposal to acquire Revance Therapeutics
Jan 6 (Reuters) - Teoxane SA offered to acquire Revance Therapeutics RVNC.O for a higher price compared to a buyout offer from Crown Laboratories last month. Teoxane's proposal provides a 16% premium ...
2025-01-06 22:15
